Researchers will seek centers of scientific excellence — ones that have the infrastructure to support their work, a ...
University research has developed a "bad look" – its overhead rates seem excessive and out of line with other benchmarks – which has made it a target for cost-cutters.
By Krystal Hu Flock Safety, a U.S. startup developing surveillance technology, has raised $275 million in new funding led by Andreessen Horowitz, as it invests in a manufacturing facility and expands ...
NEW YORK, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it has entered into an agreement with Biogen to provide research and development (R&D ...
Rigetti Computing’s strong liquidity position secures its future. Find out why RGTI stock remains a solid bet despite broader ...
More than £600,000 has been awarded to businesses to develop innovation in agriculture and food. The Welsh Government has ...
EU state aid rules apply whenever an innovation conceived in a European university or publicly funded research institution is ...
House Republicans are hoping to vote Tuesday on a stopgap bill aimed at funding the federal government through September 30 ...
The first batch of Horizon Europe projects are about to finish, and the first wave of project audits to begin. This will tell ...
Royalty Pharma plc RPRX agreed to provide Biogen with R&D funding of up to $250 million for litifilimab for systemic lupus erythematosus (SLE) and cutaneous lupus erythematosus (CLE). Litifilimab ...
Royalty Pharma (RPRX) announced that it has entered into an agreement with Biogen (BIIB) to provide research and development funding of up to $250M for litifilimab, a first-in-class ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results